Advances in NKG2D ligand recognition and responses by NK cells.
about
NKG2D Ligands in Tumor Immunity: Two Sides of a CoinMemory-Like Antigen-Specific Human NK Cells from TB Pleural Fluids Produced IL-22 in Response to IL-15 or Mycobacterium tuberculosis AntigensNK1.1- CD4+ NKG2D+ T cells suppress DSS-induced colitis in mice through production of TGF-βCeliac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells.SEP enhanced the antitumor activity of 5-fluorouracil by up-regulating NKG2D/MICA and reversed immune suppression via inhibiting ROS and caspase-3 in mice.Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions.Exploiting natural killer group 2D receptors for CAR T-cell therapy.Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients.Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation.NKG2D-NKG2D Ligand Interaction Inhibits the Outgrowth of Naturally Arising Low-Grade B Cell Lymphoma In VivoNK cell recognition of unconventional ligands.Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types.Innate immune cells for immunotherapy of autoimmune and cancer disorders.NK-92 cell, another ideal carrier for chimeric antigen receptor.NKG2D: A Master Regulator of Immune Cell Responsiveness.The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell AttackA Protective Role for NKG2D-H60a Interaction via Homotypic T Cell Contact in Nonobese Diabetic Autoimmune Diabetes PathogenesisNKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient
P2860
Q28083832-5A880996-98CE-4185-A69E-4FA3349E0A92Q28391029-C335BE33-C244-4D4C-91AE-D66C444887E1Q33844629-CE6486A4-89FF-403C-BDFF-60F33A6E3ADFQ36015747-53BBEF57-954E-4942-BA91-7AE70B2FC3FCQ37580265-DFA9B3DB-CC98-4F68-A412-CFB5A0EA1118Q38542034-6EC73767-DABB-4A08-B539-AE44EB4D5D08Q38671184-15AE8C7E-F43B-4154-B01D-A6EA9D289EEEQ38685785-F9651D9B-AEB2-4BA0-9AC7-B669CAAB7416Q39834269-ADBE3854-4D1B-4BD1-9C60-B850EC7DE233Q41067927-C8C1142F-BAAD-486E-8FD2-182F559D074FQ42771120-3495D2DD-59BB-48BF-B0FF-4936AA52D00BQ45298276-3774E448-0F59-4314-A112-DEE1F82B80EAQ47159409-47E4E65E-8283-43C1-8811-37A44E3CEC1CQ48316500-99F950DD-20CF-483B-B8FE-0F00DF5485D9Q50027824-7B1EB139-1EE5-485D-B159-D4FB9E4DB9FDQ55216305-E6F1D196-984E-46FE-8520-AFA60C86C4CCQ57169061-574DF1DF-044D-43D9-A8E7-80C455E20257Q57257678-5A951EEC-8D10-492B-AC20-CB879AF44E15Q58777071-328BFB93-8438-46E6-A880-0DEA276D37B2
P2860
Advances in NKG2D ligand recognition and responses by NK cells.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advances in NKG2D ligand recognition and responses by NK cells.
@en
type
label
Advances in NKG2D ligand recognition and responses by NK cells.
@en
prefLabel
Advances in NKG2D ligand recognition and responses by NK cells.
@en
P2860
P356
P1476
Advances in NKG2D ligand recognition and responses by NK cells.
@en
P2093
Nina Le Bert
P2860
P304
P356
10.1038/ICB.2013.111
P577
2014-01-21T00:00:00Z